Form 13-F position report

IONIS PHARMACEUTICALS INC

Reported by NOMURA HOLDINGS INC

IONS 1.75 06/15/28 CUSIP 462222AF7 Manager CIK 0001163653

Reported 0 shares, down 35,977 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2026
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 8 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-12-31 2736741
2025-03-31 331299
2025-06-30 1352327
2025-09-30 3422665
2025-12-31 397528
2026-03-31 6386917
2026-06-30 2852616
2026-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

8 quarters
Quarterly reported position history for IONIS PHARMACEUTICALS INC held by NOMURA HOLDINGS INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 0 -35,977 (-100.0%) 0 $0 2026-11-16
Q2 2026 Reduced 35,977 -49,080 (-57.7%) < 0.01% $2,852,616 2026-08-14
Q1 2026 Added 85,057 +80,032 (1592.7%) 0.02% $6,386,917 2026-05-15
Q4 2025 Reduced 5,025 -47,293 (-90.4%) < 0.01% $397,528 2026-02-17
Q3 2025 Added 52,318 +18,091 (52.9%) < 0.01% $3,422,665 2025-11-14
Q2 2025 Added 34,227 +23,246 (211.7%) < 0.01% $1,352,327 2025-08-14
Q1 2025 Reduced 10,981 -67,301 (-86.0%) < 0.01% $331,299 2025-05-15
Q4 2024 New 78,282 +78,282 (0.0%) < 0.01% $2,736,741 2025-02-14

Who else reported the position

56 managers reported IONIS PHARMACEUTICALS INC for Q3 2026.

Managers reporting IONIS PHARMACEUTICALS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
AMUNDI Unchanged 3,450,000 0 0.08% $377,640,391 9 qtrs
TENOR CAPITAL MANAGEMENT Co L P Added 97,682,000 +3,000,000 1.33% $107,830,337 6 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Unchanged 60,000,000 0 1.02% $65,965,500 5 qtrs
HIGHBRIDGE CAPITAL MANAGEMENT LLC New 57,588,000 +57,588,000 1.43% $64,132,876 1 qtr
DLD Asset Management LP Reduced 50,000,000 -10,000,000 3.82% $55,125,000 5 qtrs
CAMDEN ASSET MANAGEMENT L P CA New 25,800,000 +25,800,000 0.88% $28,240,934 1 qtr
Mirabaud Asset Management France SAS New 20,350,000 +20,350,000 14.63% $22,677,311 1 qtr
CITADEL ADVISORS LLC Reduced 17,500,000 -68,967,000 < 0.01% $19,196,853 3 qtrs
STATE STREET CORPORATION Reduced 14,075,000 -950,000 < 0.01% $15,517,000 10 qtrs
BlackRock Inc Added 13,250,000 +1,825,000 < 0.01% $14,503,583 9 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
NOTE 1.750% 6/1

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.